Recent Company News

• 02:08 PM ET Oct 02, 2026
  

  Santen Pharmaceutical completes transfer of Advanced Vision Science to SpyGlass Pharma (¥1645.5000, 0)

• 08:06 AM ET Oct 01, 2026
  

  SpyGlass Pharma Inc acquires Advanced Vision Science, Inc. for $13M ($26.00, 0.00)

• 08:54 AM ET Sep 24, 2026
  

  FDA panel to meet on 30-Oct to review NDA for RYJUNEA / SYD-101

• 07:03 AM ET Sep 22, 2026
  

  Ligand Pharmaceuticals acquires royalty and milestone interest in Santen's Ryjunea from Sydnexis for $23M ($290.07, 0.00)

• 07:58 AM ET Sep 14, 2026
  

  Santen Pharmaceutical's NDA for STN1012700 for slowing myopia progression accepted by China's CDE (¥1743.0000, 0)

• 02:50 AM ET Aug 06, 2026
  

  Santen Pharmaceutical reports Q1 net income attributable ¥7.19B vs FactSet ¥7.83B [3 est, ¥6.60-9.52B] (¥1876.0000, 0)

• 05:57 AM ET Aug 03, 2026
  

  Santen Pharmaceutical releases 2026 sustainability report (¥1869.0000, 0)

• 02:13 PM ET Jul 13, 2026
  

  Santen and KYORIN announce joint marketing agreement in Japan for Alesion Eyelid Cream 0.5% (¥2151.0000, 0)

• 09:24 AM ET Jul 13, 2026
  

  Sydnexis (private) announces FDA Adcom to review NDA for SYD-101; date to be determined

• 11:11 PM ET Jul 02, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (64 total)